Table: begin end state 1 11 cytoplasmic 12 36 transmembrane 37 41 non-cytoplasmic 42 61 transmembrane 62 81 cytoplasmic 82 99 transmembrane 100 109 non-cytoplasmic 110 131 transmembrane 132 149 cytoplasmic 150 170 transmembrane 171 181 non-cytoplasmic 182 203 transmembrane 204 232 cytoplasmic 233 256 transmembrane 257 265 non-cytoplasmic 266 285 transmembrane 286 296 cytoplasmic 297 315 transmembrane 316 320 non-cytoplasmic 321 341 transmembrane 342 367 cytoplasmic 368 391 transmembrane 392 403 non-cytoplasmic 404 428 transmembrane 429 468 cytoplasmic
Input: >BWI76_RS04865 FitnessBrowser__Koxy:BWI76_RS04865 MNGNKLSVKEKIGYGMGDAGCNIIFGAIMLFVNYFYTDIFGLAPALVGVLLLSVRVIDAV TDPIMGAMADRTRSKYGRFRPWLLWIAFPYALFSVLMFTTPEWTYNSKVIYAFVTYFLLS LTYTAINIPYCSLGSVITNDPQERVACQSYRFVMVGIATLLLSLTLLPMADWFGGEDKAK GYQMAMTVLAFIGMCMFLFCFATVRERVKPAVQTNDELKKDLKDVWKNDQWVRILLLTLC NVCPGFIRMAATMYYVTWVMQQSTHFATLFISLGVVGMMIGSMLAKVLTDRWCKLQVFFW TNIVLAVFSCAFYFFDPHATMMIMALYFLLNILHQIPSPLHWSLMADVDDYGEWKTGKRI TGISFSGNLFFLKVGLAIAGAMVGFLLSWYGYDAGAKQQSASAINGIVLLFSVIPGVGYL ITAGVVRMLKVNREFMRQIQSDLEKRRVNYSELNDYQELKTGEHVRKA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server